메뉴 건너뛰기




Volumn 10, Issue 3, 2010, Pages 239-245

Public drug expenditure in the Republic of Ireland

Author keywords

Ireland; medicines; patient co payment; pharmacoeconomic assessment; pricing; reimbursement

Indexed keywords

ADALIMUMAB; BETA1A INTERFERON; ETANERCEPT; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; REFIB; UNCLASSIFIED DRUG; GENERIC DRUG; PRESCRIPTION DRUG;

EID: 77953716138     PISSN: 14737167     EISSN: 17448379     Source Type: Journal    
DOI: 10.1586/erp.10.23     Document Type: Review
Times cited : (30)

References (8)
  • 1
    • 61549098995 scopus 로고    scopus 로고
    • Drug expenditure in Ireland 1997-2007
    • Barry M, Molloy D, Usher C, Tilson L. Drug expenditure in Ireland 1997-2007. Ir. Med. J. 101(10), 299-302 (2008).
    • (2008) Ir. Med. J , vol.101 , Issue.10 , pp. 299-302
    • Barry, M.1    Molloy, D.2    Usher, C.3    Tilson, L.4
  • 2
    • 77949388878 scopus 로고    scopus 로고
    • Pharmacoeconomic evaluation in Ireland - A review of the process
    • Tilson L, O'Leary A, Usher C, Barry M. Pharmacoeconomic evaluation in Ireland - a review of the process. Pharmacoeconomics 28(4), 307-322 (2010).
    • (2010) Pharmacoeconomics , vol.28 , Issue.4 , pp. 307-322
    • Tilson, L.1    O'Leary, A.2    Usher, C.3    Barry, M.4
  • 5
    • 84930275935 scopus 로고    scopus 로고
    • in Ireland
    • National Centre for Pharmacoeconomics (NCPE) in Ireland www.ncpe.ie
  • 8
    • 77953715762 scopus 로고    scopus 로고
    • Projecting the impact of demographic change on the demand for and delivery of healthcare in Ireland
    • (Accessed March 2010)
    • Layte R, Barry M, Bennett K et al. Projecting the impact of demographic change on the demand for and delivery of healthcare in Ireland. 2009 Research series number 13 www.esri.ie/UserFiles/ publications/20091023164031/RS013.pdf (Accessed March 2010)
    • 2009 Research Series Number 13
    • Layte, R.1    Barry, M.2    Bennett, K.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.